Skip to main content

General Nephrology

Diabetes Canada 2025 CKD Guidelines: Chronic Kidney Disease (CKD) in Diabetes
Complement Corner: Breakthroughs in complement-targeted therapeutics
Managing chronic kidney disease (CKD) in type 2 diabetes - focus on MRAs
Advances in CKD management: What is New After SGLT2 Inhibitors?
KLINRISK: Clinical Risk Prediction for Kidney Disease
Case Studies of Hyperkalemia in Heart failure and Chronic Kidney Disease
Increasing AWAREness of CKD and T2D
DOACs in Renally Impaired Patients
Filtrer les lignes directrices de KDIGO
PKD Educational Series - Listen to the Experts
Highlights from the 2021 European Society of Cardiology (ESC) Congress
Iron Deficiency Anemia: a common disorder across multiple disciplines
MRAs in diabetic kidney disease
2018 Toronto ADPKD Scientific Conference
Interactive case-based learning in ADPKD
Diabetes management and chronic kidney disease
Subsequent entry biologics: what are they and why are they?
SGLT2 inhibition in diabetic kidney disease
2017 Toronto Polycystic Kidney Disease Scientific Day
Hepatitis C: Can we eliminate a cause of CKD
Why hepatitis C matters in patients with chronic kidney disease?
Fabry disease: What every nephrologist should know
Journée québécoise de la dialyse 2016 (JQH)
Nephrology in 2016: A year in review
Clinical cases of cancer-associated thrombosis (CAT) in patients with renal dysfunction
ukidneyisup